AOD-9604 was developed to: Stimulate lipolysis (breakdown of stored fat) Inhibit lipogenesis (formation of new fat) Avoid raising IGF-1 levels Reduce impact on blood glucose Because it is a small fragment rather than the full hormone, it theoretically targets fat metabolism more specifically
Your review * Great product and customer service
Pickart, L., Vasquez-Soltero, J
This guide aims to evaluate the most effective oral form of BPC-157 currently available: Healthletic's BPC-157, a product that's becoming a top-rated favorite due to its formulation, accessibility, and quality standards
Fortunately, extensive global data indicates that this therapeutic agent presents an excellent safety profile with minimal reported issues
doi: 10.1038/ejcn.2014.46